Skip to main content

ACTIVE HEALTH FOODS, INC. COMPLETES “DREAM TEAM” BOARD OF DIRECTORS ADDING DRS. AUBREY AND OLIVER

Written by Customer Service on . Posted in Public Companies.

Los Angeles, CA, June 29, 2022 (GLOBE NEWSWIRE) — ACTIVE HEALTH FOODS, INC. (OTC: AHFD) announces that Dr. Philip Lee Miller, of Monterey, California, and Dr. Aubrey Oliver in Jamaica, have joined AHFD’s subsidiary Bioidentical Hormones, Inc. (BIO) Board of Directors.

Dr. Philip Lee Miller, MD is the Founder, Medical Director and CEO of California Age Management Institute (formerly Los Gatos Longevity Institute) established in 1996. He has been in medical practice for over 45 years. Dr. Miller has become a recognized leader in Anti-Aging integrative medicine. This started with a past association with Dr. Julian Whitaker of the Whitaker Wellness Institute in Newport Beach, California. He is currently a charter member of the American Academy for Anti-Aging Medicine. He passed the first-ever Board Exams in Anti-Aging Medicine in December 1998. www.antiaging.com

Dr. Aubrey Oliver, Functional Medicine Doctor, Naturopathic Doctor, RBT & EMBA, based in Jamaica. Dr. Oliver is a Functional Medicine Physician who treats and lectures on Preventive, Regenerative, complementary and alternative health, while remaining a strong advocate for youth empowerment and development. He also practices Bioenergetics therapy, which helps many people have an alternative to surgery and pharmaceutical therapy that reverses a variety of disorders.

Joe Wallace, AHFD President, stated “The BIO Board of Directors and Scientific Board has the leading physicians and healthcare attorney in the Bioidentical Hormone Replacement Therapy medical industry totaling more than 35 years’ experience. They have trained and advised thousands of Anti-Aging Doctors worldwide. These are the all-stars in the Anti-Aging Medical field.”

Contact:
Joseph Wallace, President
Active Health Foods, Inc.
Email: Joe@jwallace.biz

About Active Health Foods, Inc.
Active Health Foods, Inc. (AHFD) recently acquired Bioidentical Hormones, Inc. and its subsidiary Australian Menopause Centre, in addition to continuing to develop its Etrnal Cosmetics skin care subsidiary. AHFD is focused on Healthcare and the Anti-Aging Medicine industry.

Forward Looking Statements
This press release may contain forward-looking statements that involve risks and uncertainties. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology including “could”, “may”, “will”, “should”, “expect”, “plan”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, and the negative of these terms or other comparable terminology. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested in this Press Release.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.